Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
VANDEVAR v. AMERICAN RENAL ASSOCIATES HOLDINGS, INC. et al
Case Number:
2:19-cv-09074
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
October 02, 2020
Dialysis Co. Agrees To $853M Sale Amid Investor Class Deal
American Renal Associates Holdings Inc. said Friday it would be sold to a private equity firm for $853 million, unveiling the agreement the same day investors were notified of a $5.78 million deal to end class claims that the dialysis provider issued misleading financial statements.
-
January 21, 2020
Dialysis Co. Says Revenue Gains Doom Investor Class Claims
American Renal Associates Holdings Inc. has told a New Jersey federal judge that class claims over a string of allegedly misleading financial statements were improperly premised on understatements of its revenue that ultimately resulted in an additional windfall for investors.